TMU reports links between vascular health and memory after menopause. Read about the findings, evidence gaps and relevance for adults over 60.
On October 14, 2026, Toronto Metropolitan University (TMU) released an update on the Brain Health at Midlife and Menopause study (BHAMM), led by professor Natasha Rajah. The university reported links between vascular health and memory after menopause and between multilingual experience and cognitive control.
The work is based in TMU's Brain Health Equity in Aging and Memory Lab. Its central aim is to distinguish memory changes during the menopause transition from possible early markers of Alzheimer's disease.
TMU says the study combines several methods:
The approach brings brain imaging and biological measures into the same project as psychological and social information. Rather than looking at memory scores alone, researchers are examining factors that may relate to those scores during spontaneous menopause.
Rajah says clinical studies have historically not adequately accounted for sex-based biological differences. She describes a gap in understanding how female sex and sex-specific life experiences influence Alzheimer's risk and symptoms.
The focus is therefore both biological and social. TMU places the project within a broader effort to study sex, vascular health and brain aging alongside social and cultural factors.
TMU's release highlights findings in three areas:
The vascular finding draws attention to one of BHAMM's central themes: studying memory alongside measures related to blood-vessel health. The language finding places social and cultural experience in the same wider conversation.
These findings also concern different outcomes. Memory after menopause is the outcome in the vascular finding. Cognitive control is the outcome in the language finding. Keeping those distinctions clear helps avoid turning several research questions into one broad claim about brain health.
TMU also lists a Heart and Stroke Foundation of Canada Grant-in-Aid Award for Rajah's work on biological sex and menopause status. That work includes MRI biomarkers of vascular health and episodic memory at midlife.
Separate research extends the discussion into older age. A 2026 study indexed by PubMed examined menopause-related blood-protein scores across four cohorts of older women. Together the cohorts included 11,925 participants, with average cohort ages ranging from 60.7 to 72.1 years.
The abstract reports consistent associations between higher scores and cognitive aging and dementia risk. This is a different project from BHAMM, using blood-protein scores to examine menopause-related signals in later life.
For readers over 60, its relevance is the age group being studied. It shows that questions about menopause-related biology are also being investigated among older women, not only during the transition itself.
The immediate value is a more informed conversation about memory and health history. For an adult over 60, the practical task is to keep the broad research question separate from any personal health decision.
Where memory changes are a personal concern, a qualified health professional is the right person to discuss symptoms and relevant health history. Menopause history and vascular health can be part of that conversation without assuming that either explains a person's experience.
Useful questions include:
For readers looking at research rather than seeking care, the most useful next step is to locate the papers behind the university update. Participant characteristics and methods help answer whether a study is relevant to a particular question. The results should then be read in relation to the outcome actually measured.
FitBrainLab's discussion of placing memory concerns in a wider health assessment offers a related reading path. Its coverage of blood biomarkers and future memory vulnerability addresses another part of this research area.
For researchers, BHAMM's combination of methods keeps biological measures and lived experience within the same frame. For clinicians and patients, the useful shift is toward asking more specific questions rather than treating menopause and memory as a single issue.
TMU's release is a university account, not a full paper or methods report. The following gaps limit what can be concluded from it:
Without an effect size, readers cannot judge how large the reported relationship was. Without participant and methods details, they cannot assess how well it applies to other groups or how alternative explanations were handled. These are questions for the underlying papers, not details that can be supplied from the headline.
The findings do not establish cause and effect. The vascular association does not show that vascular problems caused memory difficulties or that improving vascular health would reverse them. The language finding does not show that starting another language later in life changes dementia risk.
The separate blood-protein study is also associational. Its abstract should not be treated as confirmation of BHAMM's results or as proof that menopause-related biological signals cause cognitive decline.
Neither report provides a personal Alzheimer's risk forecast. BHAMM's focus on menopause and midlife also means its findings are not direct evidence about memory change in every adult over 60.
TMU says the project hopes to identify behaviours or interventions that might support women through menopause. The update does not validate a particular prevention plan, treatment or language-learning prescription.
Rajah said she does not want to scare women. She described menopause as “a major shift and a big transition period.” That framing supports curiosity without treating the transition as a prediction of disease.
This development matters because it brings several dimensions of women's brain health into one research program. Vascular measures and menopause status sit alongside memory testing and social experience. That is a useful direction for studying cognitive aging without reducing it to a single factor.
Rajah's stated long-term goal is to inform therapies and policies that promote brain health and memory from midlife onward. FitBrainLab's view is that the lasting value of this work will rest on clear methods, transparent results and careful testing of practical ideas. Those are the steps that can turn a promising research question into useful knowledge.
Menopause research can become misleading when an association is recast as a promise about future memory, so FitBrainLab grounds its explanations in the evidence reported. Its articles help readers aged 60+ distinguish established knowledge from early or exaggerated claims about cognitive aging, using clear language without fear or medical promises.
Follow FitBrainLab for research-led insights on memory, focus, brain aging, nutrition and mental fitness after 60. Stay connected for new articles, practical guidance and ideas for a sharper, more engaged life.
Build habits that support memory, focus and a curious, connected life.
Read the Blog
